NRC Health (NRC) vs OmniAb (OABI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
OmniAb (OABI) has outperformed NRC Health (NRC) over the past year, gaining 166.3% versus a gain of 71.3%. Over five years, NRC leads with a -52.4% price change compared with -53.3% for OABI. OmniAb is the larger company by market cap ($677.5 million vs $451.7 million), about 1.5 times the size.
NRC Health pays a dividend yielding 2.94%, while OmniAb does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NRC | OABI |
|---|---|---|
| Share price | $20.42 | $4.66 |
| Market cap | $451.68M | $677.52M |
| 1-day change | +1.14% | +2.19% |
| YTD return | +8.79% | +151.89% |
| 1-year return | +71.31% | +166.29% |
| 5-year return | -52.38% | -53.26% |
| P/E ratio (TTM) | 85.08 | — |
| Forward P/E | 19.45 | — |
| EPS (TTM) | $0.24 | $-0.36 |
| Dividend yield | 2.94% | 0.00% |
| Annual dividend | $0.60 | $0.00 |
| 52-week high | $23.68 | $5.43 |
| 52-week low | $11.01 | $1.30 |
| Distance from 52-week high | -13.77% | -14.18% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +27.33% | +78.76% |
| Average volume | 115.97K | 1.47M |
| Shares outstanding | 22.12M | 145.39M |
| Employees | 357 | 89 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OABI has outperformed NRC by 95.0 percentage points over the past year.
- NRC Health offers a meaningfully higher dividend yield (2.94% vs 0.00%).
- The two companies sit in different sectors: NRC Health in Health Care and OmniAb in Healthcare.
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
About OmniAb
OABI stock →OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts.
Healthcare · Biotechnology · 89 employees
NRC vs OABI FAQ
Which is bigger, NRC Health or OmniAb?
OmniAb (OABI) is larger, with a market capitalization of $677.52M compared with $451.68M for NRC Health (NRC).
Which stock has performed better over the past year, NRC or OABI?
OABI returned +166.29% over the past 12 months, compared with +71.31% for NRC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, NRC Health or OmniAb?
NRC Health pays a dividend yielding 2.94%, while OmniAb does not currently pay a regular dividend.
Are NRC Health and OmniAb in the same industry?
No. NRC Health is in the Health Care sector, while OmniAb is in Healthcare.